self micro emulsified drug delivery system - PowerPoint PPT Presentation

About This Presentation
Title:

self micro emulsified drug delivery system

Description:

self micro emulsified drug delivery system – PowerPoint PPT presentation

Number of Views:3167
Slides: 26
Provided by: shivaram49
Tags:

less

Transcript and Presenter's Notes

Title: self micro emulsified drug delivery system


1
Self micro emulsified drug delivery system
  • Presented by
  • T.SHIVAKUMAR,STEPHEN.K
  • IV YEAR I SEM
  • KOTTAM INSTITUTE OF PHARMACY

2
WHAT IS SMEDDS
  • SMEEDS is mixture of oils, surfactants, and
    cosurfactants, which are emulsified in aqueous
    media under conditions of gentle agitation of
    digestive motility that would be encountered in
    the gastro intestinal (GI) tract.

3
AIM
  • Most of the new drug candidates in development
    today are sparingly soluble and associated with
    poor bioavailability
  • The main purpose is to prepare SMEDDS for oral
    bioavailability enhancement of a poorly water
    soluble drug

4
Bio pharmaceutical classification system
5
  • according to bio pharmaceutical classification
    system(BCS) the classII drugs have poor
    solubility and high permeability , thus the rate
    limiting process of absorption is the drug
    dissolution step. Formulation plays the major
    role in improving the rate and extent of
    absorption of such drugs from GI tract.

6
Present study
  • In the present study, an attempt was made to
    enhance the solubility and in vitro dissolution
    of candesartan cilexetil byformulating it as
    SMEDDS for filling into hard gelatin capsules.

7
Drug profile
  • Candesartan Cilexetil a prodrug is hydrolyzed to
    candesartan during absorption from the
    gastrointestinal tract., practically insoluble in
    water.
  • Category Antihypertensive Agents
  • Subcategory Angiotensin II Receptor Antagonist

8
Structure
9
Materials
  • Drug- Candesartan cilexetile-
  • Oil -Miglyol 812
  • Surfactants- Cremophor EL Tween 80
  • Cosurfactant -Labrasol

10
  • The quantity of each content will be taken
    according to the pseudo ternary phase diagram
  • This diagram is very essential in manipulation of
    ingredients in the formulation of SMEDDS

11
CONSTRUCTION OF PSUEDO TERNARY PHASE DIAGRAMS
  • The pseudoternary phase diagrams of oil,
    surfactant
  • cosurfactant, and water were developed to
    optimize the
  • formulation using a water titration method.
    The mixtures
  • of oil and surfactantcosurfactant ratios were
    diluted with
  • water in a dropwise addition. Phase diagrams
    were constructed
  • in the presence of drug to obtain the optimum
    concentrations
  • of oil, surfactant, and cosurfactant. SMEDDS
    form fine oil
  • water emulsions upon addition to an aqueous
    media under
  • gentle agitation.

12
Pseudo ternary phase diagram
The gray area indicates the microemulsion region
13
formulation
  • Four self-microemulsifying formulations were
    prepared using mixtures of oils, surfactants, and
    cosurfactants in various proportions. The
    self-microemulsification properties, droplet
    size, and zeta potential of these formulations
    were studied upon dilution with water. The
    optimized liquid SMEDDS formulation was converted
    into free flowing powder by adsorbing onto a
    solid carrier for encapsulation.

14
(No Transcript)
15
images of pure drug substance (left), solid
SMEDDS (right magnification
16
Dissolution studies
  • The dissolution characteristics of solid
    intermediates of SMEDDS filled into hard gelatin
    capsules was investigated and compared with
    liquid formulation and commercial formulation to
    ascertain the impact on self-emulsifying
    properties following conversion.

17
Results
  • The results indicated that solid intermediates
    showed comparable rate and extent of drug
    dissolution in a discriminating dissolution
    medium as liquid SMEDDS indicating that the
    self-emulsifying properties of SMEDDS were
    unaffected following conversion. Also, the rate
    and extent of drug dissolution for solid
    intermediates was significantly higher than
    commercial tablet formulation. The results from
    this study demonstrate the potential use of
    SMEDDS as a means of improving solubility,
    dissolution, and concomitantly the
    bioavailability. 

18
Comparision of dissolution studies
19
CONCLUSION
  • A SMEDDS formulation of a poorly
    water-soluble drug, candesartan cilexetil was
    formulated for direct filling into hardgelatin
    capsules for oral administrationshowed faster
    rate of drug release than the marketed product in
  • a discriminating dissolution media. The
    results from this study
  • demonstrate the utility of SMEDDS to enhance
    solubility and
  • dissolution of sparingly soluble compounds
    like candesartan
  • which may result in improved therapeutic
    performance

20
Advantages
  • Protection of sensitive drug substances.
  • The emulsion droplets will deliver the drug to GI
    mucosa in dissolved state readily accessible for
    absorption
  • When a polymer is incorporated in terms of SMEDDS
    it gives prolonged release of medicament
  • They are comprised of aqueous and oily components
    and therfore can accommodate both hydrophilic
    aswell as lipophylic drugs

21
Disadvantages
  • Chemical instabilities
  • Irritates GIT
  • Precipitation of the lipophilic drugs
  • Physical and chemical changes in crystalline
    solid in Cryogenic grinding

22
REFERENCES
  • 1. Robinson JR. Introduction semi-solid
    formulations for oral drug delivery. Bull Tech
    Gattefosse. 199689113
  • 2. Aungst BJ. Novel formulation strategies for
    improving oral
  • bioavailability of drugs with poor membrane
    permeation or
  • presystemic metabolism. J Pharm Sci.
    19938297987.
  • 3. Constantinides PP. Lipid microemulsions for
    improving drug
  • dissolution and oral absorption physical
    and biopharmaceutical
  • aspects. Pharm Res. 199512156172.
  • 4. Pouton CW. Formulation of self-emulsifying
    drug delivery systems.

23
  • Thank you.

24
APTI
  • T.siva
  • APTI/ASSN-1164
  • RAN
  • 1166

25
  • 9032796522-PRASANTHI
Write a Comment
User Comments (0)
About PowerShow.com